{"article_title": "Morning Read: Merck's Ebola vaccine gets a buyer, very bad news for digital health", "article_keywords": ["million", "package", "read", "study", "digital", "obamacare", "virus", "morning", "buyer", "bad", "health", "mercks", "ebola", "therapy", "gets", "debate", "company", "vaccine", "democratic"], "article_url": "http://medcitynews.com/2016/01/gavi-merck-ebola-vaccine/", "article_text": "TOP STORIES\n\nThe Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment to buy a vaccine being developed by Merck to protect against the Ebola virus. \u2014 Reuters\n\n\n\nThe results are in for the Scripps Translational Science Institute\u2019s Wired For Health study, a six-month randomized control trial, and it doesn\u2019t look good for digital health. The study found no short-term benefit in health costs or outcomes for patients monitoring their health with connected devices. \u2014 MobiHealthNews\n\nLIFE SCIENCES\n\nGene therapy company AveXis Inc. filed to raise up to $115 million in an IPO. The company hopes to begin pivotal studies in the U.S. and EU of AVXS-101 therapy to treat spinal muscular atrophy. \u2014 BioCentury\n\nThe frustration continues over the now-infamous JP Morgan party that added models for diversity. \u2014 Phoenix Business Journal\n\nImaging informatics company HealthMyne won FDA 510(k) clearance for its analytics software package designed for radiologist oncology-related workflow and advanced decision support. \u2014 MassDevice\n\nBluDiagnostics, a Wisconsin-based startup that is developing a saliva-based fertility test, has raised $600,000 so far this year in debt financing as part of a seed funding round. \u2014 Xconomy\n\nThe CDC has issued Zika-related guidelines for pregnant women who are getting sick and have visited or lived in countries where they could have been exposed to the virus. \u2014 The New York Times\n\nPAYERS-PROVIDERS\n\nI wonder if PETA would do some angel investing in medical simulation and the like?- STAT\n\nWhen it comes to marketing, how much is the brand of a hospital or health system actually worth? \u2014 Health Care Communication News\n\nIn its fourth-quarter earnings report, UnitedHealthcare said it lost $720 million on its Affordable Care Act-compliant plans in 2015. \u2014 FierceHealthPayer\n\nPOLITICS\n\nThe Senate\u2019s health committee announced it will not take up a major House-passed biomedical research package known as 21st Century Cures. \u2014 The Hill\n\nFollowing the Democratic debate, did anyone come out on top? \u201cThe biggest loser in the Democratic debate wasn\u2019t Hillary or Bernie, it was Obamacare,\u201d wrote Michael Cannon at the libertarian Cato Institute. \u201cClinton and Sanders inadvertently revealed that not even Democrats like Obamacare all that much.\u201d \u2014 Forbes\n\nA LITTLE EXTRA\n\nBuilding a mirror for a gigantic telescope to allow astronomers to explore space is no easy task. But the effort is interesting, despite being incredibly laborious.\n\nPhoto: Flickr user VCU CNS", "article_metadata": {"description": "Also, Gene therapy company AveXis Inc. filed to raise up to $115 million in an IPO, and HealthMyne won FDA 510(k) clearance for its analytics software package.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Also, Gene therapy company AveXis Inc. filed to raise up to $115 million in an IPO, and HealthMyne won FDA 510(k) clearance for its analytics software package.", "title": "Morning Read: Merck\u2019s Ebola vaccine gets a buyer, very bad news for digital health", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/2015/06/6792819478_ce19ec1b85_z.jpg", "updated_time": "2016-01-20T12:37:24-04:00", "url": "http://medcitynews.com/2016/01/gavi-merck-ebola-vaccine/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/2015/06/6792819478_ce19ec1b85_z.jpg", "description": "Also, Gene therapy company AveXis Inc. filed to raise up to $115 million in an IPO, and HealthMyne won FDA 510(k) clearance for its analytics software package.", "card": "summary", "title": "Morning Read: Merck's Ebola vaccine gets a buyer, very bad news for digital health - MedCity News"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,AveXis, Gavi, HealthMyne, Merck, , MedCity News", "article": {"section": "Daily", "tag": "Merck", "published_time": "2016-01-20T07:55:18-04:00", "modified_time": "2016-01-20T12:37:24-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "\u2014 ReutersThe results are in for the Scripps Translational Science Institute\u2019s Wired For Health study, a six-month randomized control trial, and it doesn\u2019t look good for digital health.\nThe study found no short-term benefit in health costs or outcomes for patients monitoring their health with connected devices.\n\u2014 MobiHealthNewsLIFE SCIENCESGene therapy company AveXis Inc. filed to raise up to $115 million in an IPO.\n\u2014 The HillFollowing the Democratic debate, did anyone come out on top?\n\u201cThe biggest loser in the Democratic debate wasn\u2019t Hillary or Bernie, it was Obamacare,\u201d wrote Michael Cannon at the libertarian Cato Institute."}